Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Incyte Corp (INCY) until September 16, 2025. Incyte Corp reported in an 8-K filed August 7, 2025 that Christiana Stamoulis resigned as Executive Vice President and Chief Financial Officer, effective September 16, 2025. The proxy statement of Incyte Corp reports total compensation of $4,936,550 for Christiana Stamoulis in fiscal 2025, including a base salary of $520,839. Disclosed compensation is on record for 5 fiscal years. Christiana Stamoulis has spoken on 21 earnings calls across 1 company, most recently for Incyte Corp on July 29, 2025. The companies whose calls Christiana Stamoulis spoke on are classified in the Healthcare sector.
“On August 4, 2025, Christiana Stamoulis, Executive Vice President and Chief Financial Officer of Incyte Corporation (the "Company"), notified the Company of her intent to step down from her role to pursue another opportunity, effective September 16, 2025.”
“In Q2, we delivered strong financial results with total product revenues of $1.06 billion, representing an increase of 17% year-over-year, driven by continued demand growth for Jakafi and Opzelura as well as the contribution from the ongoing commercial launch of Niktimvo.”
“In the first quarter of 2025, we delivered total revenues of $1.05 billion, up 20% versus the same period last year. Total product revenues of $922 million in the first quarter represent an increase of 26% year over year.”
“Our fourth quarter 2024 results reflect a strong commercial execution and continued growth with total revenues of $1.2 billion, up 16% versus the same period last year.”
“Our third quarter results reflect strong commercial execution and continued growth with total revenues of $1.14 billion, up 24% versus the same period last year.”
“Our second quarter results reflect strong commercial execution and continued growth with total revenues of $1.4 billion, up 9% versus the same period last year.”
Start not stated–2025-09-16
INCY
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Incyte Corp (INCY) | Former Executive Vice President and Chief Financial Officer | $520,839 | $4,936,550 |
| 2024 | Incyte Corp (INCY) | Former Executive Vice President and Chief Financial Officer | $712,242 | $5,397,757 |
| 2023 | Incyte Corp (INCY) | Former Executive Vice President and Chief Financial Officer | $684,288 | $5,084,485 |
| 2020 | Incyte Corp (INCY) | Executive Vice President and Chief Financial Officer | $585,468 | $4,154,250 |
| 2019 | Incyte Corp (INCY) | Executive Vice President and Chief Financial Officer | $497,096 | $4,495,668 |
